Analytical Data
-
Gene name
Wnt3a
- Application
-
Alternative Names
Wnt-3a; Wnt 3a; WNT3A protein; Wnt3a
-
Species
Bovine
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
F1MDZ7
-
Expression Region
Met1~Phe284
-
Molecular Weight
40kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Wnt3a is a pivotal member of the Wnt signaling pathway, which plays a crucial role in various biological processes including cell proliferation, differentiation, and tissue homeostasis. Dysregulation of Wnt3a has been implicated in several diseases, particularly in cancer and developmental disorders. Researchers have increasingly focused on recombinant Wnt3a protein for its potential therapeutic applications, specifically in regenerative medicine and cancer treatment. The production of recombinant Wnt3a allows for a more in-depth investigation into its mechanisms of action and interactions with other proteins within the signaling cascade. Moreover, understanding how Wnt3a influences stem cell behavior and tissue regeneration can lead to novel strategies for tissue engineering and repair. Recent advancements in recombinant protein technology have enhanced the yield and functionality of Wnt3a, facilitating in vitro and in vivo studies. Through these studies, scientists aim to elucidate the biological effects of Wnt3a, optimizing its use for targeted therapies and exploring its role in promoting regenerative processes. As research progresses, the therapeutic potential of recombinant Wnt3a continues to attract attention, with hopes of translating these findings into clinical applications for a variety of diseases.
